Mariazel Rubio-Valles

Prof. Mariazel Rubio-Valles

Instituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez, Mexico
+1
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
ARArnulfo Ramos-Jiménez
Arnulfo Ramos-Jiménez
Poor sleep quality and insomnia are increasingly linked to chronic inflammation and obesity-related metabolic dysfunction. Aerobic exercise is a promising non-pharmacological approach for enhancing sleep quality and reducing systemic inflammation; Therefore, we aim to systematically evaluate and quantify the effects of aerobic exercise interventions on subjective sleep quality, insomnia severity, and circulating markers (IL-6 and TNF-α) in adults. A systematic search was conducted in institutional databases (UNAM, UACJ) and PubMed to identify randomized controlled trials (RCTs) examining the effects of exercise on sleep and inflammation. Risk of bias was assessed using the Cochrane RoB2 tool. Meta-analyses were performed using RevMan 5.4 with random-effects models to estimate pooled mean differences (MD) and standardized mean differences (SMD), with 95% confidence intervals. Anaerobic protocols were excluded from the meta-analysis due to the insufficient availability of data. : Eleven RCTs met the inclusion criteria. Aerobic exercise showed a significant pooled effect on sleep outcomes (MD = −2.51; 95% CI: −4.80 to −0.23; p = 0.03). However, subgroup analyses for Pittsburgh Sleep Quality Index (PSQI) (MD = −2.27; p = 0.15) and Insomnia Severity Index (ISI) (MD = −2.98; p = 0.16) were not statistically significant. Two studies on IL-6 reported a non-significant reduction (SMD = −0.17; p = 0.66), with moderate heterogeneity. TNF-α results were also non-significant (SMD = 0.60; p = 0.29) with substantial variability. Our results showed that aerobic exercise may modestly improve sleep outcomes; however, current evidence does not support its effectiveness in reducing levels of IL-6 or TNF-α. Further well-controlled trials are needed to clarify its immunometabolic effects, particularly in populations with obesity or metabolic disorders.

Verified
Journal Article
Open access
ARArnulfo Ramos-Jiménez
Arnulfo Ramos-Jiménez
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
JHJavier Arturo Ramos Hernández
Javier Arturo Ramos Hernández
EREverardo Gonzalez Rodriguez
Everardo Gonzalez Rodriguez
VMVerónica Moreno-Brito
Verónica Moreno-Brito
Mitochondrial dysfunction is a key factor in the pathophysiology of major depressive disorder (MDD) and treatment-resistant depression (TRD), connecting oxidative stress, neuroinflammation, and reduced neuroplasticity. Physical exercise induces specific mitochondrial changes linked to improvements in mental health. The aim of this paper was to examine emerging evidence regarding the effects of physical exercise on mitochondrial function and treatment-resistant depression, highlighting the clinical importance of the use of mitochondrial biomarkers to personalize exercise prescriptions for patients with depression, particularly those who cannot tolerate standard treatments. Physical exercise improves mitochondrial function, enhances biogenesis and neuroplasticity, and decreases oxidative stress and neuroinflammation. Essential signaling pathways, including brain-derived neurotrophic factor, AMP-activated protein kinase, active peroxisome proliferator-activated receptor-γ coactivator-1α, and Ca2+/calmodulin-dependent protein kinase, support these effects. Most studies have concentrated on the impact of low- and moderate-intensity aerobic exercise on general health. However, new evidence suggests that resistance exercise and high-intensity interval training also promote healthy mitochondrial adaptations, although the specific exercise intensity required to achieve this goal remains to be determined. There is strong evidence that exercise is an effective treatment for MDD, particularly for TRD, by promoting specific mitochondrial adaptations. However, key gaps remain in our understanding of the optimal exercise dose and which patient subgroups are most likely to benefit from it (Graphical Abstract).

16 December 2024 in Sports Medicine
Verified
Journal Article
Closed access
PDF file
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
Francisco J. Amaro-GaheteFrancisco J. Amaro-Gahete
Francisco J. Amaro-Gahete
SCSeth A Creasy
Seth A Creasy
ARArnulfo Ramos-Jiménez
Arnulfo Ramos-Jiménez
JPJorge Alberto Perez-Leon
Jorge Alberto Perez-Leon
Isaac Chávez-GuevaraIsaac Chávez-Guevara
Isaac Chávez-Guevara

1 January 2026 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
Isaac Chávez-GuevaraIsaac Chávez-Guevara
Isaac Chávez-Guevara
HVHéctor Vázquez-Lorente
Héctor Vázquez-Lorente
LHLourdes Herrera-Quintana
Lourdes Herrera-Quintana
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
Luis LopezLuis Lopez
Luis Lopez
Francisco J. Amaro-GaheteFrancisco J. Amaro-Gahete
Francisco J. Amaro-Gahete
This systematic review investigates the role of noncoding RNAs (ncRNAs), including miRNAs, long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and transfer RNAs, in regulating mitochondrial biogenesis, dynamics, oxidative phosphorylation, and mitophagy in skeletal muscle and the potential applications of these ncRNAs in exercise molecular physiology. We conducted a comprehensive search in PubMed, Scopus, and Web of Science databases, identifying 45 relevant studies out of 2,378 records. The main findings indicate that miRNAs such as miR-128, miR-133a, miR-696, and miR-499 are critical regulators of mitochondrial function. Moreover, lncRNAs (lncEDCH1 and lncRNA-H19) and circRNA (circ-PTPN4) significantly influence mitochondrial biogenesis and function. Exercise interventions were shown to modulate the expression of these ncRNAs, particularly miR-133a and miR-696, leading to enhanced mitochondrial biogenesis and function. The review highlights the potential of these ncRNAs as biomarkers and therapeutic targets for improving mitochondrial function and treating metabolic and mitochondrial disorders. Further research is needed to explore the muscle-specific and exercise-modality-specific effects of ncRNAs to develop personalized interventions. Understanding the complex regulatory mechanisms of ncRNAs in mitochondrial adaptations can pave the way for innovative therapeutic strategies in exercise molecular physiology and metabolic health.

Verified
Journal Article
Open access
PDF file
ARArnulfo Ramos-Jiménez
Arnulfo Ramos-Jiménez
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
JAJaime Güereca Arvizuo
Jaime Güereca Arvizuo
MJMarco A. Juárez-Oropeza
Marco A. Juárez-Oropeza
JHJavier Arturo Ramos Hernández
Javier Arturo Ramos Hernández
RHRosa Patricia Hernández-Torres
Rosa Patricia Hernández-Torres
Glucose transporter type 4 (GLUT4), encoded by the SLC2A4 gene, is the final effector of insulin-stimulated glucose uptake in insulin-sensitive tissues: skeletal muscle, adipose tissue, and cardiac muscle. Its dynamic localization, retained intracellularly under basal conditions and extensively translocated to the plasma membrane upon stimulation, makes it a master regulator of glycemic homeostasis. While the canonical insulin pathway (PI3K/Akt/TBC1D4) is the most potent and specific mechanism in the postprandial state, its dysfunction is centrally associated with insulin resistance and type 2 diabetes mellitus (T2DM). Crucially, robust alternative signaling networks function completely independently of insulin to regulate GLUT4 synthesis and translocation. Prominent among these are contraction-mediated pathways in skeletal muscle, which employ calcium signaling (via CaMKII), mechanical/metabolic stress sensors (via p38 MAPK γ/δ), and AMP-activated protein kinase (AMPK). This review critically integrates current knowledge, linking the molecular architecture and post-translational modifications of GLUT4 to the complex, tissue-specific signaling networks that govern its vesicular trafficking. We emphasize the hierarchy, redundancy, and interdependence of these pathways, highlighting differences between acute translocation and chronic transcriptional adaptations. Finally, we discuss how deciphering insulin-independent mechanisms offers promising therapeutic opportunities, particularly in identifying pharmacological targets that mimic the metabolic benefits of physical exercise.

9 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
ARArnulfo Ramos-Jiménez
Arnulfo Ramos-Jiménez
MRMariazel Rubio-Valles
Mariazel Rubio-Valles
JAJaime Güereca Arvizuo
Jaime Güereca Arvizuo
MJMarco A. Juárez-Oropeza
Marco A. Juárez-Oropeza
JHJavier Arturo Ramos Hernández
Javier Arturo Ramos Hernández
RHRosa Patricia Hernández-Torres
Rosa Patricia Hernández-Torres
Glucose transporter type 4 (GLUT4), encoded by the SLC2A4 gene, is the final effector of insulin-stimulated glucose uptake in insulin-sensitive tissues: skeletal muscle, adipose tissue, and cardiac muscle. Its dynamic localization, retained intracellularly under basal conditions and massively translocated to the plasma membrane upon stimulation, makes it a master regulator of glycemic homeostasis. While the canonical insulin pathway (PI3K/Akt/TBC1D4) is the most potent and specific mechanism, its dysfunction is associated with insulin resistance and type 2 diabetes. Crucially, there are robust signaling pathways that are completely independent of insulin and regulate GLUT4 synthesis and translocation. Among these, those activated by muscle contraction are prominent, employing calcium signals (via CaMKII), mechanical/metabolic stress (via p38 MAPK γ/δ), and AMP-activated protein kinase (AMPK) activation. This review critically and comprehensively integrates current knowledge, from the molecular architecture of GLUT4 and its facilitated transport mechanism to the complex signaling networks converging on its regulation. The hierarchy, redundancy, and interdependence of these pathways are emphasized. It discusses how understanding insulin-independent mechanisms offers promising therapeutic opportunities for metabolic diseases, particularly for mimicking the benefits of exercise. Finally, future research directions are proposed to translate this molecular knowledge into novel clinical interventions.